A set of new laws is set to go into effect in Arkansas on July 1, ranging from state department name changes to an increase ...

Panelists discuss the emotional and diagnostic journey of a multiple myeloma patient and his care partner, highlighting how incidental back pain led to an unexpected cancer diagnosis, the initial ...

Multiple myeloma involves a comprehensive approach that combines blood tests, imaging, and bone marrow studies. Learn about ...

On July 2, the FDA approved linvoseltamab (Lynozyfic; Regeneron), a B-cell maturation antigen (BCMA) bispecific antibody, for the treatment of adults with relapsed or refractory multiple myeloma who ...

Patients with (RRMM) and extramedullary disease (EMD) represent a particularly high-risk population with historically poor outcomes. In a new phase 2 analysis presented at the European Hematology ...

Medically reviewed by Archana Sharma, DO There are several treatment options for multiple myeloma. Since this disease varies ...

While the introduction of novel therapies has led to substantial improvements in the outcomes of patients with newly ...

Financial, family, and logistical challenges often lead patients to choose ongoing therapies over stem cell transplantation, ...

A new form of immunotherapy is showing promising results for multiple myeloma patients in a study, an investigation found that crime-free lease addendums aren't reducing crime and increasing ...

You look at survival for patients with multiple myeloma about 20, 25 years back, it was probably measured, survival was measured, in three to five years, that's the median life expectancy for ...

Kyphoplasty is being used to treat painful osteolytic or fractured vertebrae, but will it become a key treatment option for patients with vertebral osteolyses from multiple myeloma?

Panelists discuss the growing promise of GPRC5D-targeted therapy in relapsed/refractory multiple myeloma, highlighting MonumenTAL-1 trial data showing encouraging responses in heavily pretreated ...